Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis.
Chrysi Koliaki, Julia Szendroedi, Kirti Kaul...
https://pubmed.ncbi.nlm.nih.gov/25955209Actively Recruiting
Led by German Diabetes Center · Updated on 2025-01-10
450
Participants Needed
1
Research Sites
847 weeks
Total Duration
G
German Diabetes Center
Lead Sponsor
D
Dep.of General-, Visceral- and Pediatric Surgery, HHU, Duesseldorf, Germany
Collaborating Sponsor
Researchers are investigating how bariatric surgery affects insulin sensitivity and energy metabolism in adults with obesity grades 2 and 3. The study aims to understand how insulin resistance relates to fat buildup in muscles and the liver, which can impair insulin function and glucose use. It also explores how liver inflammation links to fatty liver disease in these patients. The research focuses on uncovering the mechanisms behind insulin resistance and liver disease associated with obesity and diabetes. Participants will undergo bariatric surgery, including procedures such as biliopancreatic diversion, gastric banding, or gastric sleeve resection. These surgeries aim to reduce body weight significantly and may lead to rapid improvements in glucose tolerance before weight loss occurs. The study evaluates how these surgical interventions influence energy metabolism and insulin sensitivity over time. During the study, participants' energy metabolism will be monitored for up to five years. Researchers will assess changes in insulin sensitivity, fat storage in muscles and liver, and liver inflammation. Various tests and evaluations will be conducted to measure these outcomes, helping to identify new treatment targets for diabetes and metabolic liver disease. Safety and metabolic changes will be closely followed throughout the study period.
CONDITIONS
The Effect of Bariatric Surgery on Insulin Sensitivity and Energy Metabolism
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Total: 1 location
1
German Diabetes Center
Düsseldorf, North Rhine-Westphalia, Germany, 40225
Actively Recruiting
S
Sabine Kahl, MD
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Chrysi Koliaki, Julia Szendroedi, Kirti Kaul...
https://pubmed.ncbi.nlm.nih.gov/25955209Sabine Kahl, Klaus Straßburger, Giovanni Pacini...
https://pubmed.ncbi.nlm.nih.gov/39218222Leona Kovac, Sofiya Gancheva, Markus Jähnert...
https://pubmed.ncbi.nlm.nih.gov/38977261Theresia Sarabhai, Sabine Kahl, Sofiya Gancheva...
https://pubmed.ncbi.nlm.nih.gov/38122893Kalliopi Pafili, Sabine Kahl, Lucia Mastrototaro...
https://pubmed.ncbi.nlm.nih.gov/35988689Maria Apostolopoulou, Ruth Gordillo, Chrysi Koliaki...
https://pubmed.ncbi.nlm.nih.gov/29602794